Sign in

CIK 0001706431

  • Large accelerated filer

Vir Biotechnology, Inc.

Sign in to watch
Ticker
VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812730369
Phone
+1 415-906-4324
Business address
1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
  1. 4 Open-market sale EVP, Research & CSO sold 3,510 shares at $38.00 ($133,380)
  2. 4 Exercise or conversion EVP, Research & CSO acquired 3,700 shares (option exercise)
  3. 4 Open-market sale EVP, Research & CSO sold 3,805 shares at $31.71 ($120,638)
  4. 4 Open-market sale Chief Medical Officer sold 12,500 shares at an average $31.90 ($398,694)
  5. 4 Open-market sale EVP, Research & CSO sold 3,805 shares at an average $29.99 ($114,098)
  6. 4 Open-market sale EVP, Research & CSO sold 5,560 shares at $42.92 ($238,632)
  7. 4 Open-market sale Chief Medical Officer sold 12,500 shares at an average $32.89 ($411,159)
  8. 4 Open-market sale Chief Business Officer sold 6,943 shares at $39.15 ($271,796)
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 4 Open-market sale Chief Medical Officer sold 12,500 shares at an average $50.95 ($636,855)
  12. 4 Open-market sale EVP, Research & CSO sold 7,900 shares at $51.08 ($403,563)
  13. 4 Open-market sale Chief Medical Officer sold 12,500 shares at an average $50.90 ($636,222)
  14. 4 Open-market sale Chief Business Officer sold 11,110 shares at $47.65 ($529,404)
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market sale EVP, Research & CSO sold 7,900 shares at $47.99 ($379,090)
  18. 4 Open-market sale EVP, Research & CSO sold 7,900 shares at $48.85 ($385,876)
  19. 4 Open-market sale Chief Medical Officer sold 12,500 shares at an average $49.53 ($619,118)
  20. 4 Open-market sale CFO sold 30,000 shares at $50.06 ($1,501,731)

Page 21 of 25 · 491 filings